Applying the ABCs of Cardiovascular Disease Prevention to the 2023 AHA/ACC Multisociety Chronic Coronary Disease

Abhishek Gami1, Ian Everitt2, Roger S Blumenthal2

  • 1Department of Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.

PubMed

Insights

The 2023 guidelines offer updated chronic coronary disease (CCD) management strategies. A collaborative approach among care teams is crucial for optimizing lifelong CCD care beyond stenosis.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • The 2023 American Heart Association/American College of Cardiology guideline updates chronic coronary disease (CCD) management.
  • CCD is a lifelong condition with diverse causes, extending beyond epicardial coronary stenosis.
  • Effective management requires lifestyle interventions, medication optimization, and multidisciplinary team involvement.

Purpose of the Study:

  • To review and highlight key recommendations from the 2023 CCD guideline.
  • To emphasize the importance of a collaborative approach in managing patients with CCD.
  • To identify essential areas for interdisciplinary care coordination.

Main Methods:

  • Review of the 2023 American Heart Association/American College of Cardiology Multisociety Guideline for the Management of Patients with Chronic Coronary Disease.
  • Analysis of recommendations concerning lifestyle, pharmacotherapy, and team-based care.
  • Synthesis of information to underscore the role of collaboration.

Main Results:

  • The guideline provides updated, comprehensive recommendations for CCD management.
  • It stresses that CCD management is a lifelong process requiring tailored strategies.
  • Collaboration between cardiologists, primary care clinicians, and internists is identified as essential.

Conclusions:

  • Optimizing chronic coronary disease care necessitates a coordinated, multidisciplinary team approach.
  • The updated guideline emphasizes a holistic view of CCD, integrating lifestyle and medication management.
  • Effective implementation requires seamless communication and shared decision-making among all care providers.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11